GILEAD SCIENCES, INC. 4

What Happened
Gilead Sciences, Inc., reported as a 10% owner of Assembly Biosciences (ASMB), acquired 471,698 shares on 2026-05-26 labeled as a grant/award (transaction code A). The shares were recorded at $26.50 each, for a total reported value of $12,499,997. This is an acquisition (award) rather than a sale.

Key Details

• Transaction date: 2026-05-26. Form filed: 2026-05-27 (timely filing).
• Transaction type/code: Grant/Award/Other Acquisition (A).
• Shares acquired: 471,698 at $26.50 per share; total value $12,499,997.
• Shares owned after transaction: Not specified in the provided filing details.
• Notable footnotes: None provided in the supplied information.
• Timeliness: Filing appears timely (reported next day); not marked late.

Context
This filing reflects activity by a 10% institutional owner (Gilead), not an individual executive. Institutional acquisitions can reflect strategic, contractual, or investment-related arrangements; the filing code "A" denotes an award/grant-type acquisition rather than an open-market purchase. The report is factual and does not indicate Gilead’s motivations.